Total Payments
$502,313
2024 Payments
$49,854
Companies
37
Transactions
642
Medicare Patients
849
Medicare Billing
$136,252
Payment Breakdown by Category
Other$273,540 (54.5%)
Consulting$125,965 (25.1%)
Travel$66,350 (13.2%)
Research$18,822 (3.7%)
Food & Beverage$16,829 (3.4%)
Education$806.82 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $233,177 | 110 | 46.4% |
| Consulting Fee | $125,965 | 39 | 25.1% |
| Travel and Lodging | $66,350 | 148 | 13.2% |
| Honoraria | $40,363 | 14 | 8.0% |
| Unspecified | $18,822 | 4 | 3.7% |
| Food and Beverage | $16,829 | 319 | 3.4% |
| Education | $806.82 | 8 | 0.2% |
Payments by Type
General
$483,491
638 transactions
Research
$18,822
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $110,245 | 110 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $96,723 | 118 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $61,343 | 55 | $0 (2024) |
| Travere Therapeutics, Inc. | $53,020 | 61 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $33,825 | 36 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $33,708 | 35 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $27,628 | 28 | $0 (2024) |
| Otsuka Pharmaceutical Co., Ltd. | $18,822 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $18,572 | 58 | $0 (2024) |
| La Jolla Pharmaceutical Company | $9,437 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,854 | 80 | CALLIDITAS THERAPEUTICS US INC. ($30,678) |
| 2023 | $77,993 | 84 | Travere Therapeutics, Inc. ($34,912) |
| 2022 | $79,164 | 109 | Aurinia Pharma U.S., Inc. ($40,600) |
| 2021 | $63,921 | 95 | Aurinia Pharma U.S., Inc. ($41,770) |
| 2020 | $76,847 | 59 | Mallinckrodt Hospital Products Inc. ($24,389) |
| 2019 | $58,575 | 82 | Mallinckrodt Enterprises LLC ($27,183) |
| 2018 | $56,640 | 79 | Mallinckrodt LLC ($49,595) |
| 2017 | $39,319 | 54 | Mallinckrodt LLC ($33,468) |
All Payment Transactions
642 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/04/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 12/04/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/01/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | In-kind items and services | $217.83 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,680.00 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $106.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Nephrology | ||||||
| 11/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $48.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $141.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $99.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $47.61 | General |
| Category: Nephrology | ||||||
| 10/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $48.28 | General |
| 10/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $102.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $76.92 | General |
| 10/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Immunology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $544.40 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $360.00 | General |
| Category: Nephrology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| VIS649-201 | Otsuka Pharmaceutical Co., Ltd. | $18,822 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 191 | 305 | $90,202 | $27,447 |
| 2022 | 6 | 204 | 354 | $134,014 | $39,619 |
| 2021 | 5 | 183 | 285 | $82,546 | $24,918 |
| 2020 | 8 | 271 | 496 | $155,003 | $44,268 |
Total Patients
849
Total Services
1,440
Medicare Billing
$136,252
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 131 | $36,025 | $12,255 | 34.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 59 | $11,151 | $3,669 | 32.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 25 | $12,875 | $3,408 | 26.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 17 | $12,699 | $2,852 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 24 | $6,360 | $2,013 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $4,308 | $1,375 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 21 | $3,696 | $976.50 | 26.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 16 | $3,088 | $897.28 | 29.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 13 | 58 | $52,374 | $16,290 | 31.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 98 | $26,950 | $7,860 | 29.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 46 | $23,690 | $6,991 | 29.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 94 | $17,766 | $5,269 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 34 | $9,010 | $2,094 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 24 | $4,224 | $1,116 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 52 | 98 | $26,950 | $8,057 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 50 | 52 | $26,780 | $7,810 | 29.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 74 | $13,986 | $4,234 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 46 | $12,190 | $3,889 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 15 | $2,640 | $929.34 | 35.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 72 | 137 | $37,675 | $11,232 | 29.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 13 | 48 | $43,344 | $11,175 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 47 | 49 | $25,235 | $8,006 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 105 | $19,845 | $6,147 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 50 | $13,250 | $3,561 | 26.9% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 11 | 69 | $8,694 | $2,072 | 23.8% |
About Dr. James Tumlin, M.D
Dr. James Tumlin, M.D is a Nephrology healthcare provider based in Lawrenceville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467418053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Tumlin, M.D has received a total of $502,313 in payments from pharmaceutical and medical device companies, with $49,854 received in 2024. These payments were reported across 642 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($233,177).
As a Medicare-enrolled provider, Tumlin has provided services to 849 Medicare beneficiaries, totaling 1,440 services with total Medicare billing of $136,252. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Lawrenceville, GA
- Active Since 04/24/2006
- Last Updated 05/31/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1467418053
Products in Payments
- ACTHAR (Biological) $137,873
- LUPKYNIS (Drug) $96,723
- TARPEYO (Drug) $61,343
- Kerendia (Drug) $30,450
- Soliris (Drug) $14,308
- SOLIRIS (Drug) $9,630
- GIAPREZA (Drug) $9,437
- Ultomiris (Drug) $6,545
- Veltassa (Drug) $6,459
- Omidria (Drug) $5,305
- KRYSTEXXA (Biological) $4,209
- VYVGART (Drug) $3,750
- Non-Covered $3,375
- FARXIGA (Drug) $2,998
- TAVNEOS (Drug) $2,892
- Auryxia (Drug) $2,750
- Tavneos (Drug) $1,980
- LOKELMA (Drug) $313.44
- BENLYSTA (Biological) $294.43
- Parsabiv (Biological) $93.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Lawrenceville
Dr. Shaun Conlon, M.d, M.D
Nephrology — Payments: $38,742
Nephrology $38,742
Dr. Sharad Virmani, M.d, M.D
Nephrology — Payments: $38,080
Nephrology $38,080
Aakash Amin, M.d, M.D
Nephrology — Payments: $21,082
Nephrology $21,082
Kathryn Elmore, M.d, M.D
Nephrology — Payments: $12,236
Nephrology $12,236
Mrs. Chigozie Uko, Np-C, NP-C
Nephrology — Payments: $8,790
Nephrology $8,790
Dr. Nnamdi Nwaohiri, M.d, M.D
Nephrology — Payments: $7,814
Nephrology $7,814